PGNY
Progyny, Inc.
Key Financials
Revenue
$1.3B
↑ 304.7%
Gross Profit
$304.5M
↑ 296.0%
Net Income
$58.5M
↑ 368.7%
Operating Income
$85.3M
↑ 460.2%
Total Liabilities
$226.4M
↑ 22.3%
EPS (Diluted)
$0.65
↑ 364.3%
Total Assets
$742.4M
↑ 22.3%
Shareholders' Equity
$516.0M
↑ 22.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/7/2026 | View on SEC |
| 8-K | 8/6/2026 | View on SEC |
| SCHEDULE 13G/A | 8/6/2026 | View on SEC |
| 4 | 7/16/2026 | View on SEC |
| 144 | 7/14/2026 | View on SEC |
| 4 | 6/23/2026 | View on SEC |
| SCHEDULE 13G/A | 6/8/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PGNY |
| Company Name | Progyny, Inc. |
| CIK | 1551306 |
| Sector | Services-Misc Health & Allied Services, NEC |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 8090 |
| SIC Description | Services-Misc Health & Allied Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 212-888-3124 |